Glucokinase (ATP:d-glucose-6-phosphotransferase), expressed exclusively in liver and pancreatic islet β-cells, catalyzes the first step of glycolysis and acts as glucose sensor and metabolic signal generator in these tissues. The enzyme plays a key role in glucose homeostasis and as such is an excellent candidate for inherited defects predisposing to non-insulin-dependent diabetes mellitus (NIDDM). A compound-imperfect dinucleotide (CA)n repeat element was found ∼10-kb 3′ of the human glucokinase gene on chromosome 7p, which revealed polymorphism with alleles differing in size by 2–15 nucleotides in unrelated individuals. A polymerase chain reaction assay was developed, and genomic DNA from 275 biologically unrelated American black individuals was typed for glucokinase alleles. The differences in allelic frequencies between individuals with NIDDM and nondiabetic individuals were compared. After typing 112 diabetic and 163 nondiabetic subjects, we found five different-sized alleles, with Z defined as the most common allele, Z + 2, Z + 4, Z + 10, and Z − 15. The Z allele was more common in nondiabetic subjects than in diabetic patients (60.4 vs. 49.6%, P = 0.012). The Z + 4 allele was more common in diabetic patients than in nondiabetic subjects (20.1 vs. 12.0%, P = 0.009). After adjusting for age, sex, and body mass index, the Z + 4 allele continued to have a positive association with NIDDM (P = 0.0018), and the Z allele had a negative association with NIDDM (P = 0.0334). The Z + 4 allele, transmitted as an autosomal dominant trait, appeared to be the most significant one at this locus. No difference was found in the clinical characteristics between the diabetic patients with or without the Z + 4 allele, after adjusting for multiple comparisons. These results indicate that the dinucleotide (CA)n repeat polymorphism at the glucokinase locus is a genetic marker for NIDDM in American blacks. We estimate that the presence of at least one Z + 4 allele increases the odds of NIDDM in this racial group by 2.85 times for the same age, sex, and body mass index combination.
Skip Nav Destination
Article navigation
Original Articles|
July 01 1992
Glucokinase Gene is Genetic Marker for NIDDM in American Blacks
Ken C Chiu;
Ken C Chiu
Metabolism Division, Department of Internal Medicine, and the Division of Biostatistics, Washington University Medical School
St. Louis, Missouri
Search for other works by this author on:
Michael A Province;
Michael A Province
Metabolism Division, Department of Internal Medicine, and the Division of Biostatistics, Washington University Medical School
St. Louis, Missouri
Search for other works by this author on:
M Alan Permutt
M Alan Permutt
Metabolism Division, Department of Internal Medicine, and the Division of Biostatistics, Washington University Medical School
St. Louis, Missouri
Search for other works by this author on:
Address correspondence and reprint requests to M. Alan Permutt, MD, Metabolism Division, Washington University School of Medicine, 660 South Euclid Avenue, Box 8127, St. Louis, MO 63110.
Diabetes 1992;41(7):843–849
Article history
Received:
October 11 1991
Revision Received:
March 12 1992
Accepted:
March 12 1992
PubMed:
1612198
Citation
Ken C Chiu, Michael A Province, M Alan Permutt; Glucokinase Gene is Genetic Marker for NIDDM in American Blacks. Diabetes 1 July 1992; 41 (7): 843–849. https://doi.org/10.2337/diab.41.7.843
Download citation file:
41
Views